3.96
price up icon3.66%   0.14
after-market After Hours: 3.96
loading
Quanterix Corp stock is traded at $3.96, with a volume of 768.44K. It is up +3.66% in the last 24 hours and down -37.04% over the past month. Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
See More
Previous Close:
$3.82
Open:
$3.87
24h Volume:
768.44K
Relative Volume:
1.14
Market Cap:
$185.88M
Revenue:
$138.90M
Net Income/Loss:
$-107.15M
P/E Ratio:
-1.5694
EPS:
-2.5232
Net Cash Flow:
$-79.85M
1W Performance:
-12.39%
1M Performance:
-37.04%
6M Performance:
-24.71%
1Y Performance:
-43.59%
1-Day Range:
Value
$3.87
$4.127
1-Week Range:
Value
$3.64
$4.555
52-Week Range:
Value
$3.64
$8.77

Quanterix Corp Stock (QTRX) Company Profile

Name
Name
Quanterix Corp
Name
Phone
617-301-9400
Name
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Name
Employee
450
Name
Twitter
@QuanterixSimoa
Name
Next Earnings Date
2025-03-17
Name
Latest SEC Filings
Name
QTRX's Discussions on Twitter

Compare QTRX vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
QTRX icon
QTRX
Quanterix Corp
3.96 179.31M 138.90M -107.15M -79.85M -2.5232
ABT icon
ABT
Abbott Laboratories
104.83 180.82B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
327.65 125.72B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
87.89 111.16B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
69.78 101.28B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
82.67 47.45B 6.07B 1.06B 1.34B 1.8063

Quanterix Corp Stock (QTRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-11-25 Downgrade Canaccord Genuity Buy → Hold
Feb-01-24 Initiated Scotiabank Sector Outperform
Sep-25-23 Upgrade Canaccord Genuity Hold → Buy
Aug-08-23 Upgrade SVB Securities Market Perform → Outperform
May-23-23 Upgrade Goldman Neutral → Buy
Aug-15-22 Downgrade Canaccord Genuity Buy → Hold
Aug-09-22 Downgrade Cowen Outperform → Market Perform
Aug-09-22 Downgrade SVB Leerink Outperform → Mkt Perform
Mar-02-22 Upgrade Goldman Sell → Neutral
Oct-15-21 Resumed Cowen Outperform
Jun-04-21 Initiated Goldman Sell
View All

Quanterix Corp Stock (QTRX) Latest News

pulisher
Mar 24, 2026

Quanterix (QTRX) CLO Daniel Char granted RSUs and stock options - Stock Titan

Mar 24, 2026
pulisher
Mar 17, 2026

Quanterix (QTRX) COO gains shares from RSU vesting as stock withheld for taxes - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Quanterix (QTRX) COO Miller details PSUs, RSUs, options and shares in Form 3 - Stock Titan

Mar 17, 2026
pulisher
Mar 16, 2026

Quanterix (QTRX) CFO nets common shares from RSU vesting and tax withholding - Stock Titan

Mar 16, 2026
pulisher
Mar 16, 2026

Invenomic Capital Management LP Grows Stake in Quanterix Corporation $QTRX - MarketBeat

Mar 16, 2026
pulisher
Mar 12, 2026

Risk Report: Whats the MACD signal for Quanterix CorporationRate Cut & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 11, 2026

Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN

Mar 11, 2026
pulisher
Mar 09, 2026

Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mar 09, 2026
pulisher
Mar 09, 2026

Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com

Mar 09, 2026
pulisher
Mar 04, 2026

Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com

Mar 04, 2026
pulisher
Mar 04, 2026

William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 04, 2026
pulisher
Mar 04, 2026

Quanterix Q4 Earnings Call Highlights - Defense World

Mar 04, 2026
pulisher
Mar 03, 2026

Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st

Mar 03, 2026
pulisher
Mar 03, 2026

Quanterix (QTRX) Q4 2025 Earnings Call Transcript - AOL.com

Mar 03, 2026
pulisher
Mar 03, 2026

Quanterix Corporation Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 03, 2026
pulisher
Mar 03, 2026

Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia

Mar 03, 2026
pulisher
Mar 03, 2026

Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa

Mar 03, 2026
pulisher
Mar 03, 2026

Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus

Mar 03, 2026
pulisher
Mar 02, 2026

Quanterix Q4 2025 Earnings Call Transcript - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com Canada

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix (QTRX) Releases Revenue and Margin Projections for 202 - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix Corporation 8-K Filing Analysis - TradingView

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix (QTRX) grows Q4 revenue, deepens 2025 loss, eyes 2026 cash breakeven - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Quanterix Earnings Report: Q4 Overview - Benzinga

Mar 02, 2026
pulisher
Mar 02, 2026

Alzheimer’s blood test heads to 15,000 community events a year - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

Quanterix (QTRX) Set to Announce Q4 Earnings with Revenue Growth Expected - GuruFocus

Mar 01, 2026
pulisher
Feb 28, 2026

Quanterix (QTRX) to Release Earnings on Monday - Defense World

Feb 28, 2026
pulisher
Feb 27, 2026

Quanterix Corp expected to post a loss of 45 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

Earnings Outlook For Quanterix - Benzinga

Feb 27, 2026
pulisher
Feb 27, 2026

Quanterix Corp (QTRX) Q4 2025 Earnings Report Preview: What To L - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Quanterix to Participate in Upcoming Investor Conferences - ChartMill

Feb 26, 2026
pulisher
Feb 26, 2026

Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX - Defense World

Feb 26, 2026
pulisher
Feb 26, 2026

Biomarker firm Quanterix plans two March investor webcasts - Stock Titan

Feb 26, 2026
pulisher
Feb 25, 2026

QTRX Should I Buy - Intellectia AI

Feb 25, 2026
pulisher
Feb 24, 2026

Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat

Feb 24, 2026
pulisher
Feb 20, 2026

Investors can hear Quanterix 2025 results discussed on Mar. 2 call - Stock Titan

Feb 20, 2026
pulisher
Feb 19, 2026

Quanterix (NASDAQ:QTRX) Shares Up 0.7%Time to Buy? - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test - Clinical Lab Products

Feb 18, 2026
pulisher
Feb 14, 2026

With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing - Yahoo Finance

Feb 14, 2026
pulisher
Feb 06, 2026

Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN

Feb 06, 2026
pulisher
Feb 06, 2026

Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 04, 2026

Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView

Feb 04, 2026
pulisher
Feb 03, 2026

Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan

Feb 03, 2026

Quanterix Corp Stock (QTRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
ZBH ZBH
$87.64
price up icon 1.53%
STE STE
$223.38
price up icon 0.74%
$66.84
price up icon 0.36%
PHG PHG
$27.44
price up icon 2.66%
$72.20
price up icon 1.75%
EW EW
$82.67
price up icon 1.20%
Cap:     |  Volume (24h):